Global Bio-chem Technology Group Co (HKSE:00809) EBIT : HK$4,451 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Global Bio-chem Technology Group Co EBIT?

Global Bio-chem Technology Group Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$4,220 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,451 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Global Bio-chem Technology Group Co's annualized ROC % for the quarter that ended in Dec. 2023 was -1.46%. Global Bio-chem Technology Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 187.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Global Bio-chem Technology Group Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 90.93%.

Global Bio-chem Technology Group Co EBIT Historical Data

The historical data trend for Global Bio-chem Technology Group Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Bio-chem Technology Group Co EBIT Chart

Global Bio-chem Technology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-472.54

-1,686.10

381.12

-739.77

4,451.40

Global Bio-chem Technology Group Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-521.76	-455.84	-283.93	231.63	4,219.76

Competitive Comparison of Global Bio-chem Technology Group Co's EBIT

For the Packaged Foods subindustry, Global Bio-chem Technology Group Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Global Bio-chem Technology Group Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Global Bio-chem Technology Group Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Global Bio-chem Technology Group Co's EV-to-EBIT falls into.

Global Bio-chem Technology Group Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$4,451 Mil.

Global Bio-chem Technology Group Co (HKSE:00809) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Global Bio-chem Technology Group Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-184.218 * ( 1 - -0.17% )	/	( (14928.288	+	10405.333)	/ 2 )
=	-184.5311706	/	12666.8105
=	-1.46 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5608.607	-	2920.092	-	( 63.679	-	max(0, 13047.404	-	807.631	+	63.679	))
=	14928.288

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5209.096	-	2229.837	-	( 315.408	-	max(0, 8395.603	-	969.529	+	315.408	))
=	10405.333

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Global Bio-chem Technology Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	8439.526	/	( ( (4797.017 + max(-4542.66, 0))	+	(4220.172 + max(-4329.722, 0)) )	/	2 )
=	8439.526	/	( ( 4797.017	+	4220.172 )	/	2 )
=	8439.526	/	4508.5945
=	187.19 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(136.258	+	248.637	+	185.674)	-	(2920.092	+	0	+	2193.137)
=	-4542.66

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(140.214	+	148.332	+	189.137)	-	(2229.837	+	0	+	2577.568)
=	-4329.722

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Global Bio-chem Technology Group Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	4451.396	/	4895.196
	=	90.93 %

Global Bio-chem Technology Group Co EBIT Related Terms

Thank you for viewing the detailed overview of Global Bio-chem Technology Group Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Global Bio-chem Technology Group Co (HKSE:00809) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Global Bio-chem Technology Group Co Ltd (HKSE:00809) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hung Luen Road, Suite 1002, 10th Floor, Tower A, Cheung Kei Center, Hung Hom, Kowloon, Hong Kong, HKG

Website

http://www.globalbiochem.com

Global Bio-chem Technology Group Co Ltd manufactures and sells corn-refined products and corn-based biochemical products. Its segments are the Upstream Products segment engages in the manufacture and sale of corn starch, gluten meal, corn oil, and other corn refined products; the Amino Acids segment engages in the manufacture and sale of corn-based biochemical products, including lysine and threonine; the Corn Sweeteners segment engages in the manufacture and sale of corn-based sweetener products, including glucose, maltose, high fructose corn syrup, crystallized glucose, and maltodextrin; the Polyol Chemicals segment engages in the manufacture and sale of corn-based biochemical products, including polyol chemicals, anti-freeze products, hydrogen, and ammonia.

Executives

Ji Lin Sheng Ren Min Zheng Fu Guo You Zi Chan Jian Du Guan Li Wei Yuan Hui	2201 Interest of corporation controlled by you
Ji Lin Sheng Yuan Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Ji Lin Sheng Li Heng Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Ji Lin Zhang Bai Shan Gu Quan Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Ji Jin You Xian Gong Si	2201 Interest of corporation controlled by you
Ji Lin Sheng Nong Ye Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Zhong Guo Min Sheng Tou Zi Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Rationale (holdings) Investment Limited	2101 Beneficial owner
Zhong Min Xin Neng Tou Zi Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Rui Xuan Tou Zi Shang Hai You Xian Gong Si	2201 Interest of corporation controlled by you
Bank Of Jilin Co., Ltd.	2106 Person having a security interest in shares
Sun Zhen	2201 Interest of corporation controlled by you
Modern Agricultural Industry Investment Holdings Limited	2201 Interest of corporation controlled by you
Ji Lin Sheng Xian Dai Nong Ye Chan Ye Tou Zi Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Li Zhenghao	2201 Interest of corporation controlled by you

Global Bio-chem Technology Group Co (HKSE:00809) Headlines

No Headlines